Fill out the form to download your copy and see the results.

Remote Digital Measurement of Visual and Auditory Markers of Major Depressive Disorder Severity and Treatment Response

 

In this poster you will learn: 

  • Individuals with Major Depressive Disorder (MDD) exhibit distinct observable characteristics that are indicative of symptom severity. These have traditionally been quantified using clinical assessments, such as the Montgomery-Åsberg Depression Rating Scale (MADRS). 
  • Traditional clinical scales pose several key problems in clinical research. They can be burdensome for both patients and clinicians, subjective to clinician observation, and insensitive to change, particularly when specific symptoms are affected in response to treatment rather than the heterogeneous symptomatology of a disease. 
  • Digital measurement of MDD symptomatology poses potential solutions to each of these challenges. We evaluated the ability of remotely collected visual and auditory markers of MDD to measure symptom severity and treatment response in patients on approved antidepressants.